SCHEMBL31100334

SCHEMBL31100334

CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(Cc5ccc(N6CCC(=O)NC6=O)cc5)CC4)cc3)c2C1)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 15/20 0.71
▸ AURKB Q96GD4 8/20 0.71
▸ ABL1 P00519 4/20 0.71
▸ CDK2 P24941 4/20 0.71
▸ NTRK1 P04629 3/20 0.71
▸ RET P07949 3/20 0.71
▸ FGFR1 P11362 3/20 0.71
▸ LIMK1 P53667 3/20 0.71
▸ BCR P11274 3/20 0.71
▸ FLT3 P36888 3/20 0.71
▸ PLK4 O00444 2/20 0.71
▸ JAK2 O60674 2/20 0.71
▸ MAP4K4 O95819 2/20 0.71
▸ LCK P06239 2/20 0.71
▸ FYN P06241 2/20 0.71
▸ FES P07332 2/20 0.71
▸ LYN P07948 2/20 0.71
▸ SRC P12931 2/20 0.71
▸ PHKG2 P15735 2/20 0.71
▸ FER P16591 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31102627 0.94 AURKA (0.63) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31100901 0.94 AURKA (0.68) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31099799 0.91 AURKA (0.68) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31102271 0.91 AURKA (0.69) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31102965 0.90 AURKA (0.66) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31102219 0.89 AURKA (0.67) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31100627 0.89 AURKA (0.62) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31100910 0.89 AURKA (0.66) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31099649 0.88 AURKA (0.65) AURKAAURKBABL1CDK2NTRK1
SCHEMBL31100127 0.88 AURKA (0.65) AURKAAURKBABL1CDK2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4678638-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-01-14 — — EP claimed
WO-2024188209-A1 NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-09-19 — — WO claimed
Send feedback